Silibinin attenuates amyloid β25-35 peptide-induced memory impairments: Implication of inducible nitric-oxide synthase and tumor necrosis factor-α in mice

P. Lu, T. Mamiya, L. L. Lu, Akihiro Mouri, M. Niwa, M. Hiramatsu, L. B. Zou, T. Nagai, T. Ikejima, Toshitaka Nabeshima

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

In Alzheimer's disease (AD), the deposition of amyloid peptides is invariably associated with oxidative stress and inflammatory responses. Silibinin (silybin), a flavonoid derived from the herb milk thistle, has potent anti-inflammatory and antioxidant activities. However, it remains unclear whether silibinin improves amyloid β (Aβ) peptide-induced neurotoxicity. In this study, we examined the effect of silibinin on the fear-conditioning memory deficits, inflammatory response, and oxidative stress induced by the intracerebroventricular injection of Aβ peptide 25-35 (Aβ25-35) in mice. Mice were treated with silibinin (2, 20, and 200 mg/kg p.o., once a day for 8 days) from the day of the Aβ25-35 injection (day 0). Memory function was evaluated in cued and contextual fear-conditioning tests (day 6). Nitrotyrosine levels in the hippocampus and amygdala were examined (day 8). The mRNA expression of inducible nitric-oxide synthase (iNOS) and tumor necrosis factor-α (TNF-α) in the hippocampus and amygdala was measured 2 h after the Aβ25-35 injection. We found that silibinin significantly attenuated memory deficits caused by Aβ25-35 in the cued and contextual fear-conditioning test. Silibinin significantly inhibited the increase in nitrotyrosine levels in the hippocampus and amygdala induced by Aβ25-35. Nitrotyrosine levels in these regions were negatively correlated with memory performance. Moreover, real-time RT-PCR revealed that silibinin inhibited the overexpression of iNOS and TNF-α mRNA in the hippocampus and amygdala induced by Aβ25-35. These findings suggest that silibinin (i) attenuates memory impairment through amelioration of oxidative stress and inflammatory response induced by Aβ25-35 and (ii) may be a potential candidate for an AD medication.

Original languageEnglish
Pages (from-to)319-326
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume331
Issue number1
DOIs
Publication statusPublished - 01-10-2009
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type II
Amyloid
Tumor Necrosis Factor-alpha
Peptides
Amygdala
Hippocampus
Fear
Oxidative Stress
Memory Disorders
Injections
Alzheimer Disease
Milk Thistle
silybin
Messenger RNA
Flavonoids
Real-Time Polymerase Chain Reaction
Anti-Inflammatory Agents
Antioxidants

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Molecular Medicine

Cite this

@article{3ac4c9531fe449d79e32ea60c528f5fa,
title = "Silibinin attenuates amyloid β25-35 peptide-induced memory impairments: Implication of inducible nitric-oxide synthase and tumor necrosis factor-α in mice",
abstract = "In Alzheimer's disease (AD), the deposition of amyloid peptides is invariably associated with oxidative stress and inflammatory responses. Silibinin (silybin), a flavonoid derived from the herb milk thistle, has potent anti-inflammatory and antioxidant activities. However, it remains unclear whether silibinin improves amyloid β (Aβ) peptide-induced neurotoxicity. In this study, we examined the effect of silibinin on the fear-conditioning memory deficits, inflammatory response, and oxidative stress induced by the intracerebroventricular injection of Aβ peptide 25-35 (Aβ25-35) in mice. Mice were treated with silibinin (2, 20, and 200 mg/kg p.o., once a day for 8 days) from the day of the Aβ25-35 injection (day 0). Memory function was evaluated in cued and contextual fear-conditioning tests (day 6). Nitrotyrosine levels in the hippocampus and amygdala were examined (day 8). The mRNA expression of inducible nitric-oxide synthase (iNOS) and tumor necrosis factor-α (TNF-α) in the hippocampus and amygdala was measured 2 h after the Aβ25-35 injection. We found that silibinin significantly attenuated memory deficits caused by Aβ25-35 in the cued and contextual fear-conditioning test. Silibinin significantly inhibited the increase in nitrotyrosine levels in the hippocampus and amygdala induced by Aβ25-35. Nitrotyrosine levels in these regions were negatively correlated with memory performance. Moreover, real-time RT-PCR revealed that silibinin inhibited the overexpression of iNOS and TNF-α mRNA in the hippocampus and amygdala induced by Aβ25-35. These findings suggest that silibinin (i) attenuates memory impairment through amelioration of oxidative stress and inflammatory response induced by Aβ25-35 and (ii) may be a potential candidate for an AD medication.",
author = "P. Lu and T. Mamiya and Lu, {L. L.} and Akihiro Mouri and M. Niwa and M. Hiramatsu and Zou, {L. B.} and T. Nagai and T. Ikejima and Toshitaka Nabeshima",
year = "2009",
month = "10",
day = "1",
doi = "10.1124/jpet.109.155069",
language = "English",
volume = "331",
pages = "319--326",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

Silibinin attenuates amyloid β25-35 peptide-induced memory impairments : Implication of inducible nitric-oxide synthase and tumor necrosis factor-α in mice. / Lu, P.; Mamiya, T.; Lu, L. L.; Mouri, Akihiro; Niwa, M.; Hiramatsu, M.; Zou, L. B.; Nagai, T.; Ikejima, T.; Nabeshima, Toshitaka.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 331, No. 1, 01.10.2009, p. 319-326.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Silibinin attenuates amyloid β25-35 peptide-induced memory impairments

T2 - Implication of inducible nitric-oxide synthase and tumor necrosis factor-α in mice

AU - Lu, P.

AU - Mamiya, T.

AU - Lu, L. L.

AU - Mouri, Akihiro

AU - Niwa, M.

AU - Hiramatsu, M.

AU - Zou, L. B.

AU - Nagai, T.

AU - Ikejima, T.

AU - Nabeshima, Toshitaka

PY - 2009/10/1

Y1 - 2009/10/1

N2 - In Alzheimer's disease (AD), the deposition of amyloid peptides is invariably associated with oxidative stress and inflammatory responses. Silibinin (silybin), a flavonoid derived from the herb milk thistle, has potent anti-inflammatory and antioxidant activities. However, it remains unclear whether silibinin improves amyloid β (Aβ) peptide-induced neurotoxicity. In this study, we examined the effect of silibinin on the fear-conditioning memory deficits, inflammatory response, and oxidative stress induced by the intracerebroventricular injection of Aβ peptide 25-35 (Aβ25-35) in mice. Mice were treated with silibinin (2, 20, and 200 mg/kg p.o., once a day for 8 days) from the day of the Aβ25-35 injection (day 0). Memory function was evaluated in cued and contextual fear-conditioning tests (day 6). Nitrotyrosine levels in the hippocampus and amygdala were examined (day 8). The mRNA expression of inducible nitric-oxide synthase (iNOS) and tumor necrosis factor-α (TNF-α) in the hippocampus and amygdala was measured 2 h after the Aβ25-35 injection. We found that silibinin significantly attenuated memory deficits caused by Aβ25-35 in the cued and contextual fear-conditioning test. Silibinin significantly inhibited the increase in nitrotyrosine levels in the hippocampus and amygdala induced by Aβ25-35. Nitrotyrosine levels in these regions were negatively correlated with memory performance. Moreover, real-time RT-PCR revealed that silibinin inhibited the overexpression of iNOS and TNF-α mRNA in the hippocampus and amygdala induced by Aβ25-35. These findings suggest that silibinin (i) attenuates memory impairment through amelioration of oxidative stress and inflammatory response induced by Aβ25-35 and (ii) may be a potential candidate for an AD medication.

AB - In Alzheimer's disease (AD), the deposition of amyloid peptides is invariably associated with oxidative stress and inflammatory responses. Silibinin (silybin), a flavonoid derived from the herb milk thistle, has potent anti-inflammatory and antioxidant activities. However, it remains unclear whether silibinin improves amyloid β (Aβ) peptide-induced neurotoxicity. In this study, we examined the effect of silibinin on the fear-conditioning memory deficits, inflammatory response, and oxidative stress induced by the intracerebroventricular injection of Aβ peptide 25-35 (Aβ25-35) in mice. Mice were treated with silibinin (2, 20, and 200 mg/kg p.o., once a day for 8 days) from the day of the Aβ25-35 injection (day 0). Memory function was evaluated in cued and contextual fear-conditioning tests (day 6). Nitrotyrosine levels in the hippocampus and amygdala were examined (day 8). The mRNA expression of inducible nitric-oxide synthase (iNOS) and tumor necrosis factor-α (TNF-α) in the hippocampus and amygdala was measured 2 h after the Aβ25-35 injection. We found that silibinin significantly attenuated memory deficits caused by Aβ25-35 in the cued and contextual fear-conditioning test. Silibinin significantly inhibited the increase in nitrotyrosine levels in the hippocampus and amygdala induced by Aβ25-35. Nitrotyrosine levels in these regions were negatively correlated with memory performance. Moreover, real-time RT-PCR revealed that silibinin inhibited the overexpression of iNOS and TNF-α mRNA in the hippocampus and amygdala induced by Aβ25-35. These findings suggest that silibinin (i) attenuates memory impairment through amelioration of oxidative stress and inflammatory response induced by Aβ25-35 and (ii) may be a potential candidate for an AD medication.

UR - http://www.scopus.com/inward/record.url?scp=70349325697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349325697&partnerID=8YFLogxK

U2 - 10.1124/jpet.109.155069

DO - 10.1124/jpet.109.155069

M3 - Article

C2 - 19638571

AN - SCOPUS:70349325697

VL - 331

SP - 319

EP - 326

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -